As the U.S. death toll approaches 100,000 and confirmed cases of COVID-19 top 1.5 million in the country, there has been no national moment of mourning.
“Our large-scale, international, real-world analysis supports the absence of a clinical benefit of chloroquine and hydroxychloroquine and points to potential harm in hospitalised patients with COVID-19,” the study reads.
Unless the Trump administration steps in, every single American may soon find their local governments forced to cut essential services such as education, housing, and health programs.
Hydroxychloroquine can prevent lupus flares and increase long-term survival of patients with the disease. Without it, however, lupus patients stand to endure more pain and suffering.
